Aledade Joins CMS ACCESS Model to Expand Chronic Care Tech Support
Event summary
- Aledade approved for CMS ACCESS model to enhance chronic care support for Medicare beneficiaries.
- Program focuses on Cardio-Kidney-Metabolic (CKM) and Early CKM (eCKM) tracks for heart disease and diabetes management.
- Aledade to deploy cellular-enabled devices, pharmacist-led counseling, and data-sharing tools starting July 2026.
- Aledade’s AI-driven technology ecosystem will aggregate data from claims, EHRs, and labs to support clinicians.
The big picture
Aledade’s inclusion in the CMS ACCESS model underscores the growing emphasis on technology-enabled chronic care management within value-based care frameworks. The initiative aims to reduce Medicare spending on preventable conditions like heart disease and diabetes by leveraging primary care as the central hub. This aligns with broader industry trends toward data-driven, patient-centric healthcare solutions, positioning Aledade to capitalize on the shift toward longitudinal care support.
What we're watching
- Execution Risk
- Whether Aledade can effectively scale its technology and care management infrastructure to meet the demands of the ACCESS model.
- Market Impact
- How the ACCESS model participation will affect Aledade’s competitive positioning in the value-based care space.
- Regulatory Dynamics
- The pace at which CMS expands or modifies the ACCESS model, influencing Aledade’s long-term strategy.
Related topics